Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care

Abstract

Our study suggests that, for patients with severe CS who do not require intensive organ-supporting therapy, the use of very low doses of etomidate in medical wards should be considered.